Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • BioIVT Acquires PrecisionMed, a Leading Global Provider of Biospecimens for Neurology and Oncology Research

    Jul 19, 2023, 09:08 AM by
    PrecisionMed developed and manages the largest, private, global repository of longitudinally collected human cerebrospinal fluid (CSF) samples for scientific research.
    Full story
  • AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer

    Jul 19, 2023, 09:08 AM by
    AARDEX Group Announced as Founder Member of CancerX Initiative to Drive Innovation in the Fight Against Cancer Adherence specialists join multi-stakeholder initiative to improve long-term pathways for cancer patients and meet the challenge of oral treatments.
    Full story
  • Adlib + Generis Partnership: A “Game Changer” for Regulated Companies

    Jul 19, 2023, 09:07 AM by
    Generis and Adlib Software have announced the launch of a software connector that provides seamless integration between their industry-leading technology platforms.
    Full story
  • PromoCell Launches PromoExQ MSC Growth Medium XF for GMP Compliant Isolation and Expansion of Mesenchymal Stem Cells

    Jul 19, 2023, 09:07 AM by
    PromoCell has announced the launch of PromoExQ MSC Growth Medium XF, a serum- and xeno-free cell culture medium designed for GMP-compliant isolation and expansion of mesenchymal stem cells for cell therapy manufacturing applications.
    Full story
  • Vibrating Capsule Repurposed For Assessment of ‘Visceral Acuity’

    Jul 19, 2023, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the Laureate Institute for Brain Research (Tulsa, Oklahoma) are repurposing a vibrating capsule that is FDA-cleared for treating chronic constipation to study how people sense the hidden signals originating in their gastrointestinal (GI) system.
    Full story
  • Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers

    Jul 18, 2023, 09:20 AM by
    Acquisition expands customers' ability to accelerate their advanced bioconjugate and payload delivery design innovation
    Full story
  • Cytel acquires French group stève consultants to further expand value evidence and real-world analytics capabilities

    Jul 18, 2023, 09:20 AM by
    Cytel Inc. has acquired stève consultants, specialists in market access, real-world (RWE), and health economics and outcomes research (HEOR).
    Full story
  • Trends from the Trenches Part 1: Infrastructure Upheaval

    Jul 18, 2023, 01:00 AM by User Not Found
    Bio-IT World | After years of threatening to pass the baton, Chris Dagdigian was absent from this year’s Trends from the Trenches session at the 2023 Bio-IT World Conference & Expo.
    Full story
  • Endor Labs Recognized as a Cool Vendor in the 2023 Gartner® Cool Vendors™ in Platform Engineering for Scaling Application Security Practices

    Jul 14, 2023, 08:52 AM by
    Startup, Endor Labs has been named a Gartner Cool Vendor in Platform Engineering for Scaling Application Security Practices, highlighting the company’s commitment to providing cutting-edge solutions that address the challenges faced by platform engineering and DevSecOps teams in meeting application security needs.
    Full story
  • Inizio Engage launches Patient Access Services – an integrated suite of patient support services to enhance access and adherence for specialty therapies

    Jul 14, 2023, 08:52 AM by
    Full story
  • DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer

    Jul 14, 2023, 08:51 AM by
    DoseMe, a leading provider of precision dosing software for therapeutic drug monitoring and creators of DoseMeRx and DoseMe Analytics, today announced the appointments of Paul Edwards to Chief Executive Officer, John Hardesky to the role of Chief Commercial Officer and Dr. Sharmeen Roy, PharmD, BCPS, to Chief Strategy and Science Officer.
    Full story
  • GigaIO Introduces the First Ever 32 GPU Single-Node Supercomputer for Generative AI and Accelerated Computing

    Jul 14, 2023, 08:51 AM by
    Full story
  • Procurement and Technology Onboarding: How Big Pharma Picks New Tools

    Jul 14, 2023, 01:00 AM by User Not Found
    Bio-IT World | A panel of pharma representatives talked about their tech acquisition pipelines last month at the Bio-IT World Conference & Expo. Representatives from Roche, Janssen, and Novartis outlined their strategies for acquiring new technologies and the pitfalls they look for.
    Full story
  • Genedata Announces Partnership with Dragonfly Therapeutics to Support Novel Immune Engager R&D

    Jul 13, 2023, 09:59 AM by
    Genedata Biologics supports R&D processes at innovative biopharmaceutical company developing breakthrough immunotherapies for the treatment of cancer and chronic inflammatory diseases
    Full story
  • European Commission Levies Record Fines on Illumina, GRAIL Merger

    Jul 12, 2023, 10:45 AM by User Not Found
    Bio-IT World | The European Commission announced this morning that it has fined Illumina and GRAIL approximately €432 million and €1,000 respectively—both record fines—for implementing their proposed merger before approval by the Commission, in breach of EU merger control rules.
    Full story
  • Phastar's B Corp™ certification affirms its status as a 'force for good' organization

    Jul 12, 2023, 09:53 AM by
    Phastar's B Corp™ certification affirms its status as a 'force for good' organization International certification recognizes leading global specialist biometrics CRO’s commitment and leadership in corporate social responsibility and sustainable business practices.
    Full story
  • Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements

    Jul 12, 2023, 09:53 AM by
    Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements Cary, North Carolina- July 11th, 2023: Skyelarke, a health tech company, has announced some significant new additions to SkyePay, a cutting-edge patient payment technology built by and for the clinical research industry.
    Full story
  • NCC Group Welcomes New Chief Technology Officer, Siân John

    Jul 12, 2023, 09:53 AM by
    NCC Group, one of the world’s largest security consultancies with over 35 global offices, 2,000 employees in 12 countries and 14,000 clients, today appointed Siân John as Chief Technology Officer. Joining from Microsoft and with 25 years of cybersecurity experience across strategy, business risk, privacy, and technology, Siân will drive innovation, insights and intelligence at the firm through close interaction with clients, industry, and academia.
    Full story
  • Cotiviti Introduces Prepay Claim Review Solution for Coordination of Benefits (COB) Validation

    Jul 11, 2023, 09:32 AM by
    New addition to comprehensive COB suite enables health plans to improve claim accuracy while reducing provider and member abrasion
    Full story
  • JPA Health Unveils GRETEL Trails: Revolutionizing Integrated Healthcare Marketing with AI-Powered Insight Engine and Chatbot

    Jul 11, 2023, 09:32 AM by
    Full story
  • «
  • 81
  • 82
  • 83 (current)
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy